Gahzi Abdullah A, Elterman Dean S, Hassouna Magdy
Department of Urology, Toronto Western Hospital, Toronto, Canada.
Int Neurourol J. 2016 Sep;20(3):270-272. doi: 10.5213/inj.1632536.268. Epub 2016 Sep 23.
The objective of this study was to describe our experience using sacral neuromodulation to treat urinary urgency, frequency, urge incontinence, and chronic urinary retention in patients with cardiac pacemakers. With the increasingly widespread use of InterStim for bladder function restoration, we are seeing more complex patients with multiple comorbidities, including cardiac conditions. Herein, we report 3 cases of individuals with cardiac pacemakers who underwent InterStim implantation to treat urinary conditions. This study is a case series of 3 patients with cardiac pacemakers who underwent sacral neuromodulation to treat refractory voiding dysfunction. The initial patient screening for InterStim therapy involved percutaneous nerve evaluation (PNE), in which a temporary untined lead wire was placed through the S3 foramen. Patients who did not respond to PNE proceeded to a staged implant. All patients in this study had a greater than 50% improvement of their urinary symptoms during the initial trial and underwent placement of the InterStim implantable pulse generator (IPG). Postoperative programming was done under electrocardiogram monitoring by a cardiologist. No interference was observed between the Inter- Stim IPG and the cardiac pacemaker. In this group of patients, sacral neuromodulation in the presence of a cardiac pacemaker appears to have been safe.
本研究的目的是描述我们使用骶神经调节治疗心脏起搏器患者尿急、尿频、急迫性尿失禁和慢性尿潴留的经验。随着InterStim用于膀胱功能恢复的日益广泛应用,我们看到越来越多患有多种合并症(包括心脏疾病)的复杂患者。在此,我们报告3例植入心脏起搏器的患者接受InterStim植入以治疗泌尿系统疾病的情况。本研究是一个病例系列,包括3例植入心脏起搏器的患者接受骶神经调节治疗难治性排尿功能障碍。InterStim治疗的初始患者筛查包括经皮神经评估(PNE),其中通过S3孔放置一根临时无固定装置的导线。对PNE无反应的患者进行分期植入。本研究中的所有患者在初始试验期间泌尿系统症状改善超过50%,并接受了InterStim植入式脉冲发生器(IPG)的植入。术后程控由心脏病专家在心电图监测下进行。未观察到Inter-Stim IPG与心脏起搏器之间存在干扰。在这组患者中,存在心脏起搏器时进行骶神经调节似乎是安全的。